longeveron inc.

longeveron inc.

NASDAQ:LGVN
Longeveron Inc.

Chart

Detailed Quote

Longeveron Inc is a biotechnology company developing cellular therapies for specific ageing-related and life-threatening conditions. It is involved in sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer's disease, Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS), and Hypoplastic left heart syndrome (HLHS).

Featured Articles and Interviews
Press Releases

Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer's Association International Conference that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in Patients with Alzheimer's Disease

Longeveron® Appoints Marie Washburn as Chief Financial Officer

New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer's Disease Accepted for Poster Presentation at the 2026 Alzheimer's Association International Conference

The Conversation (0)